top-banner

It Is Not Carved in Stone – The Need for a Genetic Reevaluation of Variants in Pediatric Cardiomyopathies

A recent article published by our colleagues in the Journal of Cardiovascular Development and Disease reports that in patients with childhood-onset cardiomyopathies, nearly 30% of reported genetic variants are found to be (likely) benign upon reclassification. Given the impact on patient management and cascade screening, this finding underlines the importance of continuous genetic counseling and variant reclassification.

Abstract

(1) Background: In cardiomyopathies, identification of genetic variants is important for the correct diagnosis and impacts family cascade screening. A classification system was published by the American College of Medical Genetics and Genomics (ACMG) in 2015 to standardize variants’ classification. The aim of the study was to determine the rate of reclassification of previously identified variants in patients with childhood-onset cardiomyopathies.

(2) Methods: Medical records of patients and their relatives were screened for clinical and genetic information at the Department of Congenital Heart Defects and Pediatric Cardiology, German Heart Center Munich. Patients without an identified genetic variant were excluded from further analyses. Previously reported variants were reevaluated by the ACMG criteria in November 2021.

(3) Results: Data from 167 patients or relatives of patients with childhood-onset cardiomyopathy from 137 families were analyzed. In total, 45 different genetic variants were identified in 71 individuals. Classification changed in 29% (13/45) with the greatest shift in “variants of unknown significance” to “(likely) benign” (9/13).

(4) Conclusions: In patients with childhood-onset cardiomyopathies, nearly a third of reported genetic variants change mostly to more benign classes upon reclassification. Given the impact on patient management and cascade screening, this finding underlines the importance of continuous genetic counseling and variant.

Reference

Westphal DS et al. It Is Not Carved in Stone-The Need for a Genetic Reevaluation of Variants in Pediatric Cardiomyopathies. J Cardiovasc Dev Dis. 2022 Jan 25;9(2):41. doi: 10.3390/jcdd9020041. PMID: 35200695; PMCID: PMC8875742. https://www.mdpi.com/2308-3425/9/2/41

Related articles

Carrier screening: A comprehensive guide to genetic health and reproductive planning

Carrier screening is a genetic test designed to identify whether an individual carries a gene with changes (mutations) associated with inhe..

Trisomy awareness month: Understanding trisomy 13

Trisomy 13, also known as Patau syndrome, is a genetic condition in which cells in the body have three copies of chromosome 13 instead of t..

Genetic Testing: A powerful tool in the fight against cardiovascular diseases

Introduction Cardiovascular disease (CVD) is a major health issue as it remains a leading cause of death worldwide [1]. CVD is responsib..

Related articles

Carrier screening: A comprehensive guide to genetic health and reproductive planning

Carrier screening is a genetic test designed to identify whether an individual carries a gene with changes (mutations) associated with inhe..

Trisomy awareness month: Understanding trisomy 13

Trisomy 13, also known as Patau syndrome, is a genetic condition in which cells in the body have three copies of chromosome 13 instead of t..

Genetic Testing: A powerful tool in the fight against cardiovascular diseases

Introduction Cardiovascular disease (CVD) is a major health issue as it remains a leading cause of death worldwide [1]. CVD is responsib..

Latest articles

10 facts about DNA

Every year on April 25th, DNA Day celebrates the discovery of DNA’s double helix and the advances we’ve made in understanding genetics...

Genetic causes of neurodevelopmental disorders: Insights from trio exome sequencing

Neurodevelopmental disorders (NDDs) have diverse genetic origins, making diagnosis challenging. A new study analyzing over 1,100 pediatric ..

Newly published study demonstrates insights in anti-EGFR re-challenge and the role of liquid biopsy in metastatic colorectal cancer

Colorectal cancer (CRC) remains one of the most prevalent and deadly cancers worldwide, with a significant number of cases presenting at an..

Latest articles

10 facts about DNA

Every year on April 25th, DNA Day celebrates the discovery of DNA’s double helix and the advances we’ve made in understanding genetics...

Genetic causes of neurodevelopmental disorders: Insights from trio exome sequencing

Neurodevelopmental disorders (NDDs) have diverse genetic origins, making diagnosis challenging. A new study analyzing over 1,100 pediatric ..

Newly published study demonstrates insights in anti-EGFR re-challenge and the role of liquid biopsy in metastatic colorectal cancer

Colorectal cancer (CRC) remains one of the most prevalent and deadly cancers worldwide, with a significant number of cases presenting at an..

RELATED PRODUCTS

CARDIAC AND AORTIC PANELS KNOW&MANAGE

Diagnosing cardiac or aortic disorders using clinically actionable gene panels

ARRYTHMIAS & CARDIOMYOPATHIES PANEL

Testing for pathogenic variants in genes associated with arrythmogenic diseases, including primary arrythmia syndromes and cardiomyopathies

DILATED CARDIOMYOPATHY

Testing for pathogenic variants in genes associated with dilated cardiomyopathy

OUR NETWORK